Back
Global Partners LP Vs. Novo Nordisk AS Industry Stock Comparison
Buy
54
GLP
Global Partners LP
Last Price:
$46.47
Seasonality Move:
1.22%
Sell
29
NVO
Novo Nordisk AS
Last Price:
$86.31
Seasonality Move:
6.68%
Buy
54
Global Partners LP (GLP)
is a Buy
Is Global Partners LP a Buy, Sell or Hold?
-
The current Global Partners LP [GLP] share price is $46.75. The Score for GLP is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
GLP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $86.26. The Score for NVO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GLP Stock Price Chart
What is Global Partners LP's stock price today?
-
The Global Partners LP share price today is $46.75Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLP is experiencing slight selling pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $86.26Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight selling pressure.
GLP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.3 | Sell |
Relative Strength Index (14 RSI): | 41.17 | Sell |
Chaikin Money Flow: | -11038 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.25 - 53.81) | Sell |
Bollinger Bands (100): | (43.6 - 51.52) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.82 | Sell |
Relative Strength Index (14 RSI): | 33.28 | Sell |
Chaikin Money Flow: | -2810015 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (85.82 - 108.16) | Sell |
Bollinger Bands (100): | (98.91 - 129.19) | Sell |
GLP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.79 | Sell |
20-day SMA: | 48.55 | Sell |
50-day SMA: | 50.26 | Sell |
200-day SMA: | 46.03 | Buy |
8-day EMA: | 47.14 | Sell |
20-day EMA: | 48.46 | Sell |
50-day EMA: | 49.14 | Sell |
200-day EMA: | 45.96 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 85.9 | Buy |
20-day SMA: | 93.8 | Sell |
50-day SMA: | 102.02 | Sell |
200-day SMA: | 123.53 | Sell |
8-day EMA: | 86.69 | Sell |
20-day EMA: | 92.03 | Sell |
50-day EMA: | 101.02 | Sell |
200-day EMA: | 114.52 | Sell |
Global Partners LP Earnings Growth & GLP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $0.61 per share.
Global Partners LP Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |